Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 1E (PP2C domain containing) is a nuclear serine/threonine-protein phosphatase that requires Mg2+ or Mn2+ for activity. It dephosphorylates and inactivates multiple substrates, including the multifunctional Ca2+/calmodulin-dependent protein kinases (such as CAMK4 and CAMK2), PAK, and AMPK, thereby regulating signal transduction events, actin cytoskeleton organization, and cell morphology. Its dysregulation is implicated in disorders such as Mulibrey nanism, osteoblastoma, and possibly cancers. It belongs to the PPM family of phosphatases and its main functional annotation is protein serine/threonine phosphatase activity[1][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1E (PP2C domain containing) (PPM1E).